|
Innovative Immunotherapy for HER2-Positive Breast Cancer: Harnessing Engineered B Cells
Innovative Immunotherapy for HER2-Positive Breast Cancer: Harnessing Engineered B Cells
Background
Breast cancer, particularly the subtype overexpressing the HER2 gene, presents a significant unmet medical need due to severe therapeutic challenges. Roughly 15-20% of all breast cancer cases exhibit overexpression or amplification of HER2, a tyrosine...
Published: 3/26/2026
|
Updated: 10/13/2025
|
Inventor(s): Pietro Genovese, Lucia Sereni, Andrea Bianchi
Keywords(s): Breast Cancer
Category(s): Technology Classifications > Disease Area > Oncology, Technology Classifications > Invention Type > Therapeutics > Cell Therapy
|
